1 |
Tobert J. A. (1988), Efficacy and Long-term adverse effect pattern of lovastatin, J. American Cardiology. 62, 28-34
|
2 |
Serizawa, N., Nakagawa, K., Hamano, K., Tsujita, Y., Terahara, A., and Kuwano, H. (1983), Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B), J. Antibiot. 36, 604-607
DOI
PUBMED
|
3 |
Finkelstein D. B. and C. Ball (1992), Biotchnology of filamentous fungi, pp241-251, Butterworth-Heineman, London, U.K
|
4 |
Hutchinson C. R., J. Kennedy, C. Part, S. Kendrew, K. Auclair, and J. Vedras (2000), Aspect of the biosynthesis of non-aromatic fimgal polyketides by iterative polyketide synthases, Antonie Van Leewenhoek. 78, 287-295
DOI
ScienceOn
|
5 |
Kennedy J., K. Auclair, S. G. Kendrew, C. Park, J. S. Vederas, and C. R. Hutchinson (1999), Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis, Science 284, 1368-1372
DOI
PUBMED
ScienceOn
|
6 |
Demain, A. L. (1999), Phannaceutically active secondary metabolites of microorganism, Appl. Microbiol. Biotechnol. 52, 455-463
DOI
PUBMED
ScienceOn
|
7 |
Hucher F. H. and W. H. Oleson (1973), Simplified spectrophotometrin for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A, J. Lipid Res. 14, 625-631
PUBMED
|
8 |
Moon Y. J., K. H. Yeum, and C. K. Sung (2000), Screening of 3-hydroxy-3 methylglutaryl- coenzyme A reductase inhibitor in vitro and its applicarion to pullets, Korean J. Food and Nutr. 15, 307-313
|
9 |
Slater E. E. and J. S. Macdonald (1988), Mechanism of action and biological profile of HMG-CoA reductase inhibitor, Drugs. 36, 72-82
DOI
PUBMED
|
10 |
Lee J. W., S. M. Lee, K. S. Gwak, J. Y. Lee, and I. G. Choi (2006), Screening of edible mushrooms for the production of lovastatin and its HMG-CoA reductase inhibitory activity, Kor. J. Microbiol. 42, 83-88
|
11 |
Endo A. (1992), The discovery and development of HMG-CoA reductase inhibitors, J. Lipid Reseach. 33, 1569-1582
|
12 |
Albers A. W., J. Chen, G. Kuron, V. Hunt, C. Hoffman, J. Rothrock, M. Lopez, H. Joshua, E. Hairris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Alberts-Schonberg, O. Hensens, J. Hirshchfield, K. Hoogsteen, and J. Springer (1980), Mevinolin: a highly potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase and a cholesterollowing agent. Proc. Natl. Acad. Sci. 77, 3957-3961
DOI
ScienceOn
|
13 |
Kinl S. J., H S. Ko, and H S. Kinl (2008), Development of seed culture using soybean for mass production of ;ovastatin with Aspergillus terreus ATCC 20542 mutant, J. Korean Soc. Food Sci. Nutr. 37, 666-670
DOI
ScienceOn
|
14 |
Stryer, L. (1995), In Biochemistry, W. H. Freeman & Company, New York. Vol. 4, pp685-712
|
15 |
Greenspan M. D. and J. B. Yudkorvitz (1985), Mevinolin acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis, J. Bacteriol. 162, 704-707
PUBMED
|
16 |
Hutchinson C. R and I. Fujii (1995), Polyketide synthase gene manipulation: a structure-function approach in engineering novel antibiotics, Annu. Rev. Microbiol. 49, 201-238
DOI
ScienceOn
|
17 |
Park J. H. and H. S. Kim (2004), Production of lovastatin in solid culture, J. Korean Soc. Food Sci. Nutr. 33, 566-570
|
18 |
Hoffman, W. F., A. W. Alberts, P. S. Anderson, J. S. Chen, R. L. Smith, and A. K. Willard (1986), 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, 4 side chain ester derivatives of mevinolin, J. Med. Chem. 29, 849-852
DOI
PUBMED
|
19 |
Kumar M. S., P. M. Kimar, H. M. Sarnail, and A. K. Sadhukhan (2000), A rapid technique for screening of lovastatin-producing strains of Aspergillus terreus by agar plug and Neurospora crassa bioassay, Joumal of Microbiological Methods 40, 99-104
DOI
ScienceOn
|